We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleImplications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.AuthorsValenti, L; Aghemo, A; Stättermayer, A F; Maggioni, P; De Nicola, S; Motta, B M; Rumi, M G; Dongiovanni, P; Ferenci, P; Colombo, M; Fargion, SAbstractHomozygosity for the PNPLA3 p.I148M polymorphism influences steatosis and fibrogenesis in chronic hepatitis C (CHC).PublicationAlimentary pharmacology & therapeutics, 2012, Vol 35, Issue 12, p1434ISSN1365-2036Publication typeJournal ArticleDOI10.1111/j.1365-2036.2012.05109.x